This randomized clinical trial compares the effects of adjunctive raloxifene with antipsychotic therapy vs antipsychotics alone on illness severity in women with refractory schizophrenia.
This meta-analysis of 6 placebo-controlled studies examines whether the baseline severity of schizophrenia influences the efficacy of antipsychotic drugs.
In a 2-center, randomized, controlled, assessor-blind, parallel group trial, Moritz and coauthors examine the long-term efficacy of group metacognitive training for schizophrenia in order to explore whether previously established effects were sustained.
Umbricht and colleagues aimed to determine the efficacy and safety of bitopertin, a glycine reuptake inhibitor, in patients with schizophrenia and predominant negative symptoms who were stable while taking an antipsychotic treatment. Goff provided a related editorial.
Lane and coauthors examine the clinical and cognitive efficacy and safety of add-on treatment of sodium benzoate for schizophrenia.